Click for best price
Rheumatoid Arthritis RA Drugs Market Size, Share 2023
Rheumatoid arthritis (RA) is an inflammatory disease that progresses over time affecting the joints. The symptoms aggravate over time, which is why medication for RA becomes essential to stop the inflammation. There is no permanent cure for rheumatoid arthritis, though increasing research activities regarding the same indicate that remission of symptoms is achieved when treatment begins in the initial stages with strong medications known as disease-modifying antirheumatic drugs (DMARDs).
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis (RA) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis (RA) Drugs. This report contains market size and forecasts of Rheumatoid Arthritis (RA) Drugs in global, including the following market information:
Global Rheumatoid Arthritis (RA) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Rheumatoid Arthritis (RA) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NSAIDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis (RA) Drugs include AbbVie, Roche, Merck, HEYL Chemisch-pharmazeutische Fabrik, Johnson & Johnson, Amgen, Inc., Pfizer, Bristol-Myers Squibb and UCB, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatoid Arthritis (RA) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis (RA) Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, by Type, 2022 (%)
NSAIDs
Analgesic Drugs
Corticosteroids
DMARDs
Biological Therapies
JAK-inhibitors
Global Rheumatoid Arthritis (RA) Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Rheumatoid Arthritis (RA) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis (RA) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Rheumatoid Arthritis (RA) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatoid Arthritis (RA) Drugs, market overview.
Chapter 2: Global Rheumatoid Arthritis (RA) Drugs market size in revenue.
Chapter 3: Detailed analysis of Rheumatoid Arthritis (RA) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatoid Arthritis (RA) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rheumatoid Arthritis (RA) Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rheumatoid Arthritis (RA) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatoid Arthritis (RA) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatoid Arthritis (RA) Drugs Overall Market Size
2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size: 2022 VS 2029
2.2 Global Rheumatoid Arthritis (RA) Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatoid Arthritis (RA) Drugs Players in Global Market
3.2 Top Global Rheumatoid Arthritis (RA) Drugs Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis (RA) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Rheumatoid Arthritis (RA) Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rheumatoid Arthritis (RA) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Rheumatoid Arthritis (RA) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis (RA) Drugs Market Size Markets, 2022 & 2029
4.1.2 NSAIDs
4.1.3 Analgesic Drugs
4.1.4 Corticosteroids
4.1.5 DMARDs
4.1.6 Biological Therapies
4.1.7 JAK-inhibitors
4.2 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis (RA) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Rheumatoid Arthritis (RA) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2029
6.3.2 US Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.3.3 Canada Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.3.4 Mexico Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2029
6.4.2 Germany Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4.3 France Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4.4 U.K. Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4.5 Italy Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4.6 Russia Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.4.8 Benelux Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2029
6.5.2 China Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.5.3 Japan Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.5.4 South Korea Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.5.6 India Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2029
6.6.2 Brazil Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.6.3 Argentina Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2029
6.7.2 Turkey Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.7.3 Israel Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
6.7.5 UAE Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2029
7 Rheumatoid Arthritis (RA) Drugs Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.1.4 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.2.4 Roche Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.3.4 Merck Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 HEYL Chemisch-pharmazeutische Fabrik
7.4.1 HEYL Chemisch-pharmazeutische Fabrik Company Summary
7.4.2 HEYL Chemisch-pharmazeutische Fabrik Business Overview
7.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.4.4 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.4.5 HEYL Chemisch-pharmazeutische Fabrik Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.5.4 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Company Summary
7.6.2 Amgen, Inc. Business Overview
7.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.6.4 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.6.5 Amgen, Inc. Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.7.4 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 UCB
7.9.1 UCB Company Summary
7.9.2 UCB Business Overview
7.9.3 UCB Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.9.4 UCB Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.9.5 UCB Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.10.4 GSK Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.11.4 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Company Summary
7.12.2 Abbott Laboratories Business Overview
7.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.12.4 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.12.5 Abbott Laboratories Key News & Latest Developments
7.13 Teva Pharmaceutical
7.13.1 Teva Pharmaceutical Company Summary
7.13.2 Teva Pharmaceutical Business Overview
7.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.13.4 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue in Global Market (2018-2023)
7.13.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rheumatoid Arthritis (RA) Drugs Market Opportunities & Trends in Global Market
Table 2. Rheumatoid Arthritis (RA) Drugs Market Drivers in Global Market
Table 3. Rheumatoid Arthritis (RA) Drugs Market Restraints in Global Market
Table 4. Key Players of Rheumatoid Arthritis (RA) Drugs in Global Market
Table 5. Top Rheumatoid Arthritis (RA) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rheumatoid Arthritis (RA) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rheumatoid Arthritis (RA) Drugs Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis (RA) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 32. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 36. Roche Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 40. Merck Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. HEYL Chemisch-pharmazeutische Fabrik Company Summary
Table 43. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 44. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. HEYL Chemisch-pharmazeutische Fabrik Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 48. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Amgen, Inc. Company Summary
Table 51. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 52. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen, Inc. Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 56. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 60. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. UCB Company Summary
Table 63. UCB Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 64. UCB Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. UCB Key News & Latest Developments
Table 66. GSK Company Summary
Table 67. GSK Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 68. GSK Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. GSK Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 72. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Abbott Laboratories Company Summary
Table 75. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 76. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Abbott Laboratories Key News & Latest Developments
Table 78. Teva Pharmaceutical Company Summary
Table 79. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 80. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Teva Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Rheumatoid Arthritis (RA) Drugs Segment by Type in 2022
Figure 2. Rheumatoid Arthritis (RA) Drugs Segment by Application in 2022
Figure 3. Global Rheumatoid Arthritis (RA) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis (RA) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis (RA) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis (RA) Drugs Revenue in 2022
Figure 8. By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 16. US Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 28. China Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. UCB Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GSK Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
